Activistic adds Nehemiah to its charity suite as Ralli goes to market
Activistic (ASX:ACU), an Australian micro-donations business has added another charity to its Ralli app as it prepares for go-to-market launch in the UK.
The Nehemiah Project will be ACU’s eighth core charity to be added to Ralli which already includes Children’s Heart Surgery Fund, Tearfund, Emmaus Glasgow, Scotty’s Little Soldiers, Grassroots Suicide Prevention, TEMWA, Vital for Children and ARC Youth Counselling.
Outside of its ‘core charities’, ACU’s Ralli app also has more than 80 charities already on-boarded and able to receive donations. ACU says it has at least five top UK charities per cause including animal welfare, disaster relief, health and research, and poverty.
As part of its marketing push, ACU will implement various marketing methods and channels to launch Ralli in the UK, leveraging the established communities of each partner charity as well as social media channels and email communication.
To assist with the Ralli go-to-market launch, ACU has brought in specialist PR company ‘Wolfstar PR’. Wolfstar is expected to raise ACU’s market visibility and drive awareness amongst grass roots donors around the UK. In the past, Wolfstar has worked with organisations including PayPal and Sony as well as major charities Comic Relief and Save the Children.
Ralli has also engaged strategic app marketing agency ‘Switched On Media’ who will provide expertise in building digital campaigns to drive downloads with high conversion rates.
Nigel Lee, Chairman of Activistic’s Strategic Advisory Board said: “We believe the partner charities will see outstanding benefits from using Ralli and its low cost, secure and streamlined payment technology which avoids issues that often hinder donation collection. Leveraging the marketing assets of our partners will greatly help us raise awareness of the app in this initial go-to-market stage.”
More about Activistic
ACU’s business premise is to deliver the lowest possible cost to both the donor and the charity by billing donors’ mobile phone bills directly, thereby avoiding the need for donor’s payment information such as credit/debit card or bank account details.
The revolutionary approach has never been done before, and ACU retains exclusivity over its unique payments workaround having agreed cornerstone deals with all major telecommunications providers prior to listing on the ASX last year.
Activistic allows subscribers to donate to any cause in any region from a simple mobile/online interface. ACU also provides significant cost savings to beneficiaries; with the nominated charity receiving 85% of the donated amount as opposed to ~32% in the traditional model. Traditional fundraising costs can exceed 65% meaning almost two thirds of donor funds goes towards payments processing rather than helping good causes.
Short-term positions in small, early stage ASX companies,
with high potential and near term price catalysts.
Focusing on resource exploration, early-stage tech, and biotech.
Exceptional opportunities across a broad range of
early-stage growth sectors with strong management.
Seeking 1,000% plus returns across medium to long-term holds.
Longer-term positions in a variety of sectors.
Seeking strong management where traction is established and have entered into a growth phase.
S3 Consortium Pty Ltd (CAR No.433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information only. Any advice is general advice only. Neither your personal objectives, financial situation nor needs have been taken into consideration. Accordingly you should consider how appropriate the advice (if any) is to those objectives, financial situation and needs, before acting on the advice.
Conflict of Interest Notice
S3 Consortium Pty Ltd does and seeks to do business with companies featured in its articles. As a result, investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of this article. Investors should consider this article as only a single factor in making any investment decision. The publishers of this article also wish to disclose that they may hold this stock in their portfolios and that any decision to purchase this stock should be done so after the purchaser has made their own inquires as to the validity of any information in this article.
The information contained in this article is current at the finalised date. The information contained in this article is based on sources reasonably considered to be reliable by S3 Consortium Pty Ltd, and available in the public domain. No “insider information” is ever sourced, disclosed or used by S3 Consortium.